Target intelligence / Profile preview

Chymotrypsinogen B pseudogene

Molecular classification
Pseudogene, Genetically related to serine protease family
01

Overview

Chymotrypsinogen B pseudogene is a non-coding DNA sequence at the human locus ENSG00000240338. It is categorized as a pseudogene because it shares sequence homology with active chymotrypsinogen B genes, which encode serine proteases involved in digestion, but it does not produce a functional protein. While some pseudogenes have regulatory roles in gene expression or may serve as genetic markers, the chymotrypsinogen B pseudogene has no documented biological activity, therapeutic relevance, or disease association. It should not be considered a therapeutic target for pharmacological intervention. The term "pseudogene" indicates the locus does not encode a functional protein or serve as a typical drug target, receptor, transporter, or enzyme. "Chymotrypsinogen B" is a member of the serine protease family, but as a pseudogene, this variant is inactive. There is no evidence in literature supporting any canonical therapeutic or diagnostic use for chymotrypsinogen B pseudogene. For research on therapeutic targets, functional gene family members such as chymotrypsinogen A or B (protein-coding) should be considered instead.

02

Biological functions

No direct biological functionPotential regulatory RNA transcripts (rare cases)
03

Disease associations

No direct disease involvement documentedPotential role in gene regulation (general pseudogene characteristic)Potential as genetic markers in cancer (general pseudogene characteristic)

Beyond the preview

Go deeper on Chymotrypsinogen B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chymotrypsinogen B pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call